Amgen Inc. AMGN NASDAQ

Amgen Inc. (AMGN) has shown strong revenue growth over the past 3 years, expanding from $26.3B to $36.7B (average +11.9%/yr). Net income reached $7.7B, reflecting solid earnings growth at +17.3%/yr on average. The net profit margin is 21%, which is high. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 70.8% (high), with a -4.9pp trend over the period. With a $189B market cap and MOAT composite score of 81/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (80/100, Pass) — proving strong growth momentum
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 40-year history, the company was profitable in 38 of 40 years — an excellent long-term track record
• INCOME (85/100, Pass) — proves strong profitability and pricing power
• MOAT (81/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 64/100 with 4/7 criteria passed.